Tci Wealth Advisors, Inc. Apellis Pharmaceuticals, Inc. Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$46.59 - $66.96 $4,193 - $6,026	-90 Reduced 22.61%	308 $20,000
Q4 2022 Feb 06, 2023	BUY	$43.24 - $61.04 $3,891 - $5,493	90 Added 29.22%	398 $20,000
Q4 2021 Jan 24, 2022	BUY	$30.74 - $49.16 $9,467 - $15,141	308 New	308 $15,000
Q3 2021 Oct 29, 2021	SELL	$31.4 - $69.84 $3,516 - $7,822	-112 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$40.9 - $64.9 $1,636 - $2,596	40 Added 55.56%	112 $7,000
Q1 2021 Apr 29, 2021	BUY	$40.8 - $57.39 $2,937 - $4,132	72 New	72 $3,000

300

111M

2.63M

845K

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.67B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.